Within these pages, you will discover articles that showcase our latest discoveries, collaborative projects, and the impact of our open-access approach. This section offers a behind-the-scenes look at the innovative work unfolding at the SGC, featuring contributions from our scientists, partners, and community members. Interested in getting first the latest news from SGC?
By Aled Edwards, SGC CEO
At the SGC, we want to help stimulate the discovery of new medicines – yet we explicitly do not file for patents and promptly release information that is customarily kept secret until publication. How are we helping drug discovery by releasing our…
By Aled Edwards, SGC CEO
In the early months of 2003, I made a trip to England to interview for the SGC Chief Executive position, which was to be based in Oxford. Prior to the trip, I had agreed with my colleague Cheryl Arrowsmith that it would be an exciting opportunity for…
By Aled Edwards, SGC CEO
The origins of the Structural Genomics Consortium (SGC) can be traced back to 1999 when Rob Cooke (then at GlaxoWellcome) floated an idea past counterparts in other pharmaceutical companies as to whether a pre-competitive consortium in the field of…
Categories